Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Ankylosing Spondylitis Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ankylosing Spondylitis Treatmentmarket, defines the market attractiveness level of Ankylosing Spondylitis Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ankylosing Spondylitis Treatment industry, describes the types of Ankylosing Spondylitis Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ankylosing Spondylitis Treatment market and the development prospects and opportunities of Ankylosing Spondylitis Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ankylosing Spondylitis Treatment market in Chapter 13.
By Player:
UCB
Johnson & Johnson
Janssen Biotech
Abbvie
Boehringer Ingelheim
Amgen
Merck
By Type:
NSAIDs
TNF Inhibitors
By End-User:
Juveniles
Adults
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ankylosing Spondylitis Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ankylosing Spondylitis Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ankylosing Spondylitis Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ankylosing Spondylitis Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ankylosing Spondylitis Treatment Market Analysis and Outlook to 2022
-
7.1 Global Ankylosing Spondylitis Treatment Consumption (2017-2022)
-
7.2 United States Ankylosing Spondylitis Treatment Consumption (2017-2022)
-
7.3 Europe Ankylosing Spondylitis Treatment Consumption (2017-2022)
-
7.4 China Ankylosing Spondylitis Treatment Consumption (2017-2022)
-
7.5 Japan Ankylosing Spondylitis Treatment Consumption (2017-2022)
-
7.6 India Ankylosing Spondylitis Treatment Consumption (2017-2022)
-
7.7 South Korea Ankylosing Spondylitis Treatment Consumption (2017-2022)
8 Region and Country-wise Ankylosing Spondylitis Treatment Market Analysis and Outlook to 2028
-
8.1 Global Ankylosing Spondylitis Treatment Consumption Forecast (2022-2028)
-
8.2 United States Ankylosing Spondylitis Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Ankylosing Spondylitis Treatment Consumption Forecast (2022-2028)
-
8.4 China Ankylosing Spondylitis Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Ankylosing Spondylitis Treatment Consumption Forecast (2022-2028)
-
8.6 India Ankylosing Spondylitis Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Ankylosing Spondylitis Treatment Consumption Forecast (2022-2028)
9 Global Ankylosing Spondylitis Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Ankylosing Spondylitis Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global NSAIDs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Ankylosing Spondylitis Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Juveniles Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adults Consumption and Growth Rate (2017-2022)
10 Global Ankylosing Spondylitis Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Ankylosing Spondylitis Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global NSAIDs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ankylosing Spondylitis Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Juveniles Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Adults Consumption Forecast and Growth Rate (2022-2028)
11 Global Ankylosing Spondylitis Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ankylosing Spondylitis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ankylosing Spondylitis Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ankylosing Spondylitis Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ankylosing Spondylitis Treatment Market Competitive Analysis
-
14.1 UCB
-
14.1.1 UCB Company Details
-
14.1.2 UCB Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 UCB Ankylosing Spondylitis Treatment Product and Service
-
14.2 Johnson & Johnson
-
14.2.1 Johnson & Johnson Company Details
-
14.2.2 Johnson & Johnson Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Johnson & Johnson Ankylosing Spondylitis Treatment Product and Service
-
14.3 Janssen Biotech
-
14.3.1 Janssen Biotech Company Details
-
14.3.2 Janssen Biotech Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Janssen Biotech Ankylosing Spondylitis Treatment Product and Service
-
14.4 Abbvie
-
14.4.1 Abbvie Company Details
-
14.4.2 Abbvie Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Abbvie Ankylosing Spondylitis Treatment Product and Service
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Details
-
14.5.2 Boehringer Ingelheim Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer Ingelheim Ankylosing Spondylitis Treatment Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Ankylosing Spondylitis Treatment Product and Service
-
14.7 Merck
-
14.7.1 Merck Company Details
-
14.7.2 Merck Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck Ankylosing Spondylitis Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ankylosing Spondylitis Treatment
-
Figure Ankylosing Spondylitis Treatment Picture
-
Table Global Ankylosing Spondylitis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ankylosing Spondylitis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ankylosing Spondylitis Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ankylosing Spondylitis Treatment Consumption by Country (2017-2022)
-
Figure United States Ankylosing Spondylitis Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Ankylosing Spondylitis Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Ankylosing Spondylitis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Ankylosing Spondylitis Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Ankylosing Spondylitis Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ankylosing Spondylitis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Ankylosing Spondylitis Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Ankylosing Spondylitis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ankylosing Spondylitis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ankylosing Spondylitis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ankylosing Spondylitis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ankylosing Spondylitis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ankylosing Spondylitis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NSAIDs Consumption and Growth Rate (2017-2022)
-
Figure Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Juveniles Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global NSAIDs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Juveniles Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ankylosing Spondylitis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ankylosing Spondylitis Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Ankylosing Spondylitis Treatment Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Ankylosing Spondylitis Treatment Product and Service
-
Table Janssen Biotech (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Ankylosing Spondylitis Treatment Product and Service
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Ankylosing Spondylitis Treatment Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Ankylosing Spondylitis Treatment Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Ankylosing Spondylitis Treatment Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Ankylosing Spondylitis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Ankylosing Spondylitis Treatment Product and Service
-
